ICD code M08.3 – Seronegative juvenile polyarthritis

Key takeaways

M08.3 is billable and valid for FY2026, effective October 1, 2025, and applies only to patients under 16.

Seronegative means a documented negative rheumatoid factor test, so without lab evidence an unspecified code applies instead.

Polyarticular involvement means five or more joints confirmed in a single examination, not counted across several visits.

Practice management software like Pabau carries an ICD-10 code library that checks M08.3 documentation before a claim goes out.

ICD-10 Code M08.3: Code description and billable status

ICD-10 Code M08.3 is a billable, specific ICD-10-CM diagnosis code effective for dates of service on or after October 1, 2025 (FY2026 edition).

It is valid for reimbursement submission to Medicare, Medicaid, and most commercial payers when the clinical documentation supports the diagnosis.

Payer-specific policies may add coverage requirements beyond the CMS defaults. Verify prior authorization rules with individual commercial carriers before submitting, particularly for biologic therapies ordered alongside this diagnosis. According to the CMS ICD-10 codes page, FY2026 updates became effective October 1, 2025.

Clinical overview: What is juvenile rheumatoid polyarthritis (seronegative)?

Juvenile rheumatoid polyarthritis (seronegative) is a subtype of chronic childhood arthritis affecting five or more joints in patients under 16. Laboratory testing confirms the negative rheumatoid factor. The condition belongs to the broader category now more commonly called juvenile idiopathic arthritis (JIA) in clinical practice. ICD-10-CM retains the older “juvenile rheumatoid arthritis” (JRA) terminology in the M08 code titles.

Coders carry the cost of that split vocabulary. A rheumatologist may chart “seronegative polyarticular JIA,” while the ICD-10-CM tabular lists “juvenile rheumatoid polyarthritis (seronegative).” Both describe M08.3, so a coder searching the index for a JIA-specific entry will come up empty and may settle for a less specific code.

• Age criterion: Onset must occur before age 16. Arthritis developing at 16 or older falls under adult codes (M06 category), not M08.
• Seronegative status: Rheumatoid factor must be tested and documented as negative. “RF not tested” does not satisfy the seronegative qualifier.
• Polyarticular involvement: Five or more joints affected. Four-joint involvement is oligoarticular and maps to a different M08 subcode.
• Chronicity: Symptoms must persist for at least six weeks to meet JIA classification criteria. Acute, transient joint inflammation uses different coding pathways.
• JRA vs JIA terminology: Both terms refer to overlapping clinical entities. ICD-10-CM uses JRA language, while current clinical literature generally favors JIA. Verify against AAPC’s ICD-10-CM lookup when mapping chart notes to code titles.

ICD-10-CM M08.3 vs other JIA subtypes: The M08 code family

M08.3 sits within the M08 parent category, which covers the full spectrum of juvenile arthritis subtypes. Choosing the wrong M08 subcode is the most common denial trigger on these claims, and M08.3 and M08.4 are the pair most often swapped. The table below maps the M08 family, as referenced by the CDC/NCHS ICD-10-CM tool.

Note that M08.3 does not carry site-specific extensions the way M08.4 does. The seronegative polyarticular code is reported at the M08.3 level whichever joints are involved. Five or more affected joints make site specificity impractical within the code structure. Three documented findings decide the subcode, and the diagram below runs them in the order a coder should check them.

Inclusion terms, exclusion notes, and applicable diagnoses

The ICD-10-CM tabular specifies which diagnoses are captured by M08.3 and which require separate coding or a different code altogether. Misreading these notes is a common audit trigger.

Inclusion terms

M08.3 includes seronegative polyarticular juvenile idiopathic arthritis and RF-negative polyarticular JRA documented in patients under 16. Chart notes using “seroneg polyarticular JIA,” “RF-negative JRA, polyarticular subtype,” or equivalent clinical phrasing all map here.

Excludes1 notes (cannot be coded with M08.3)

• Arthropathy in Whipple’s disease (M14.8-): Systemic disease with joint involvement — use the underlying disease code.
• Felty’s syndrome (M05.0-): Seropositive RA with splenomegaly and leukopenia, which sits in the adult seropositive category.
• Juvenile dermatomyositis (M33.0-): An inflammatory myopathy with skin involvement, coded in the connective tissue chapter.
• Psoriatic juvenile arthropathy (L40.54): Juvenile arthritis with psoriasis, coded from the dermatology chapter instead.

Excludes2 notes (may be coded additionally)

Excludes2 conditions can coexist with M08.3 and be coded separately when documented. These include juvenile arthritis in diseases classified elsewhere (M08.8-) and certain reactive arthropathies. When the rheumatologist documents both a seronegative polyarticular pattern and a coexisting systemic condition, review the Excludes2 list before adding a second code.

Documentation requirements for accurate M08.3 coding

Every M08.3 claim needs five elements in the clinical record. Missing any one of them creates an audit vulnerability, even where the diagnosis is clinically correct.

• Patient age at onset: The record must establish that symptoms began before the patient’s 16th birthday. Coders working from encounter notes on a 17-year-old patient need onset documentation, because the diagnosis may have been established years earlier.
• RF-negative lab result: A specific rheumatoid factor test result documented as negative. The ordering provider’s narrative alone (“appears seronegative”) is insufficient for audit purposes. The lab report must be in the record.
• Joint count of 5 or more: The physical examination note must enumerate at least five distinct affected joints. A cumulative count across multiple visits does not satisfy this requirement, so the five joints must appear in a single clinical assessment.
• Chronicity (6 weeks minimum): The clinical record should reflect symptom duration of at least six weeks, consistent with JIA classification criteria. Single-visit acute presentations do not meet M08.3 criteria.
• Subtype specification: The provider must document the polyarticular seronegative subtype explicitly. Documenting the RF-negative result and the joint count also works, as long as the coder can infer the subtype under ICD-10-CM coding guidelines.

Age-restricted codes share one weakness: the age qualifier has to be supported by the chart rather than assumed from the patient’s current birthday. Structured encounter templates that prompt for onset date, joint count, and lab results keep that evidence in the note instead of in the coder’s inbox.

Common coding errors and how to avoid them

Three errors account for the majority of M08.3 denials and audit findings. Each is preventable with the right documentation workflow.

Seropositive vs seronegative misclassification

The most frequent error is selecting M08.3 without a negative rheumatoid factor result in the record. Confirm the lab result before the code goes on the claim. Where RF is positive, M08.3 no longer describes the encounter. The coder then works from the documented joint count and clinical presentation to find the correct subcode. Where RF testing has not been performed at all, use an unspecified code and flag the chart for follow-up testing.

Adult patient coded with a juvenile code

M08 codes are age-restricted. Applying M08.3 to a 19-year-old patient whose JIA was diagnosed in childhood but is being actively treated in adulthood triggers an age-conflict edit. Once a patient transitions out of pediatric care, the claim should use the appropriate adult seronegative RA code from the M05-M06 category. Solid denial management in healthcare includes an age-conflict edit check before submission.

Joint count below the polyarticular threshold

A patient with four inflamed joints documented in a single visit does not meet the polyarticular criterion for M08.3. The correct code in that scenario is M08.4 (pauciarticular). Coders sometimes total joints mentioned across multiple visits to reach five, which the documentation does not support. The five-joint threshold must be met in a single clinical examination to justify M08.3.

Using unspecified M08.0 when subtype is documented

If the rheumatologist has documented seronegative polyarticular JIA in the chart, M08.0 (unspecified) is wrong. CMS guidelines require the most specific code supported by documentation. M08.0 is appropriate only when the subtype genuinely cannot be determined from the clinical record.

CPT codes commonly used with ICD-10 Code M08.3

M08.3 is reported alongside CPT codes for office visits, lab panels, imaging, and infusion therapy depending on the patient’s treatment stage. The table below covers the pairings that commonly accompany this diagnosis, with notes on medical necessity documentation. Our CPT code reference carries the full descriptor and billing notes for each one.

CPT code pairing recommendations reflect current clinical practice patterns and do not imply guaranteed reimbursement. Payer-specific medical necessity policies govern coverage decisions for biologics and imaging. Always verify prior authorization requirements before submitting high-cost procedure codes alongside M08.3.

M08.3 billing and reimbursement considerations

M08.3 carries no relative value unit, because it describes a diagnosis rather than a procedure. Reimbursement flows through the CPT codes submitted alongside it. The diagnosis drives medical necessity for those CPT codes, which is why documentation completeness has a direct financial impact.

Biologic therapies ordered for seronegative polyarticular JIA represent the highest-cost claims paired with M08.3. Payers typically require step therapy documentation showing that conventional DMARDs were tried and failed before approving biologics. Without that step-therapy history in the record, prior authorization is frequently denied however accurately M08.3 is coded.

Practices processing ERA remittances see three CARC reason codes recur on M08.3 claims: age conflict, diagnosis-procedure mismatch, and missing seronegative documentation. Each denial type has its own appeal pathway, and each is preventable with the documentation checklist set out above.

How practice management software supports M08.3 billing accuracy

An M08.3 denial is usually set in motion in the encounter note, days or weeks before the claim goes out. By the time the rejection arrives, the note has been signed and the patient has gone home. Moving the check into the documentation step is what changes the outcome.

Practice management software like Pabau ships with a built-in ICD-10 code library. Pediatric rheumatology practices can use it to prompt for the required evidence at the point of care. When a provider selects M08.3, the system surfaces a check. It asks for the RF-negative lab result, a joint count of five or more, and the patient’s age. That turns smoother claims management into a documentation habit rather than a monthly clean-up job.

Pabau also connects to Claim.MD for electronic claim submission to thousands of US payers, with real-time eligibility verification and 835 remittance processing. Biologic infusion codes raise the stakes on a lapsed prior authorization. Checking eligibility before the appointment catches it while there is still time to renew.

Reduce M08.3 claim denials with Pabau

Pabau’s ICD-10 code library and Claim.MD clearinghouse connection work together on pediatric rheumatology claims. Confirm the RF result, the joint count, and the patient’s age before submission.

Book a demo

Conclusion

ICD-10 Code M08.3 describes a narrow patient population: children under 16 with RF-negative arthritis affecting five or more joints. The code itself is straightforward. The denials come from documentation that falls short of it, through missing lab results, under-counted joints, and age-conflict edits on transitioning patients.

Treat the three criteria as a pre-submission check rather than an appeal argument. The cost of this code then drops to the minutes it takes to read the chart. Book a demo to see how Pabau prompts for M08.3 documentation while the patient is still in the room.

Continue your research

Want to know what a payer counts as a submittable claim? Clean claim sets out the fields a claim needs before it leaves the practice.

Want to understand what happens when M08.3 claims get denied? Denial management in healthcare explains the appeal workflow and CARC reason codes that appear on rejected pediatric arthritis claims.

Looking for a clearinghouse that validates diagnosis-procedure pairings before submission? Claim.MD clearinghouse outlines how Pabau’s integrated clearinghouse connection catches edit failures on ICD-10 code claims.

Frequently asked questions